ITOR delays 10-Q, cites financial review; plans Rule 12b-25 timing

Rhea-AI Filing Summary

REDOX International Group, Corp. (ITOR) filed a Form 12b-25 (NT 10-Q), stating it cannot file its Quarterly Report on Form 10-Q for the period ended August 31, 2025 without unreasonable effort and expense.

The company is completing its financial statement review and believes the Form 10-Q will be filed within the period described under Rule 12b-25(b)(2)(ii).

	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING		OMB APPROVAL
			OMB Number:              3235-0058
			Expires:          September 30, 2028
			Estimated average burden hours per response ……………… 2.50
			SEC FILE NUMBER
			333-255055
			CUSIP NUMBER 46116J102

(Check one):		☐ Form 10-K   ☐  Form 20-F   ☐  Form 11-K   ☒ Form 10-Q   ☐  Form 10-D   ☐  Form N-SAR   ☐  Form N-CSR
		For Period Ended:	August 31, 2025
		☐   Transition Report on Form 10-K
		☐   Transition Report on Form 20-F
		☐   Transition Report on Form 11-K
		☐   Transition Report on Form 10-Q
		☐   Transition Report on Form N-SAR
		For the Transition Period Ended:

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

REDOX International Group, Corp.

Full Name of Registrant

Former Name if Applicable

17875 Von Karman Avenue Suite 150

Address of Principal Executive Office (Street and Number)

Irvine, California 92614

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The Company’s Quarterly Report on Form 10-Q for the quarterly period ended August 31, 2025 cannot be filed within the prescribed time period without unreasonable effort and expense. The Company is in the process of completing its financial statement review and believes that the Form 10-Q will be filed within the period described under Rule 12b-25(b)(2)(ii).

PART IV — OTHER INFORMATION

(1)		Name and telephone number of person to contact in regard to this notification
		Han-Wen Ou		(323)		909-2866
(Name)				(Area Code)		(Telephone Number)

(2)		Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
		Yes ☐      No ☒
		10-K for period ended: February 28, 2025 10-Q for period ended: May 31, 2025
(3)		Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
		Yes ☐     No ☒
		If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

2

REDOX International Group, Corp.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

	REDOX International Group, Corp.
October 16, 2025	By:	/s/ Han-Wen Ou
		Han-Wen Ou Chief Executive Officer

3